Yilan Zeng
Public Health Clinical Center of Chengdu(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatitis C virus research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Alternation of Gut Microbiota in Patients with Pulmonary Tuberculosis(2017)190 cited
- → Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu(2020)184 cited
- → S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates(2021)162 cited
- → An efficient primary screening of COVID‐19 by serum Raman spectroscopy(2021)63 cited
- → Factors Associated with Mother-to-child Transmission of Hepatitis B Virus Despite Immunoprophylaxis(2015)55 cited
- → Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice(2018)52 cited
- → Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD(2020)40 cited
- → Real‐world study on HBsAg loss of combination therapy in HBeAg‐negative chronic hepatitis B patients(2022)31 cited
- → Cathepsin H–Mediated Degradation of HDAC4 for Matrix Metalloproteinase Expression in Hepatic Stellate Cells(2017)29 cited
- → Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study(2022)29 cited